Search results
Q1 2024 Acumen Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Singapore Finance· 2 months agoParticipants Alex Braun; Head of Investor Relations; Acumen Pharmaceuticals Inc Daniel O'Connell; Chief Executive Officer, Director; Acumen Pharmaceuticals Inc W. Matthew Zuga; Chief Financial ...
INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 2 months agoINmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript May 11, 2024 INmune Bio, Inc. isn’t...
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Zacks via Yahoo Singapore Finance· 2 months agoIt was a busy week in the biotech sector with lots of important regulatory and pipeline updates....
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
Zacks via Yahoo Singapore Finance· 2 months agoData from a mid-stage study show that Sage's (SAGE) experimental oral drug failed to show a...
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 3 months agoAcumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript March 26, 2024 Acumen...
Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks
Insider Monkey via Yahoo Singapore Finance· 8 months agoIn this article, we discuss Farallon Capital: a global and diversified hedge fund and its top stock...
REUTERS NEWS SCHEDULE AT 10 p.m. GMT / 6:00 a.m. SGT
Reuters via Yahoo Singapore Finance· 8 months agoHere are the top stories and upcoming coverage plans for Reuters text service as of 10 p.m. GMT / 6:00 a.m. SGT. For a full schedule of news and events, go to our editorial calendar on Reuters ...
Reasons to Retain FLEX Stock in Your Portfolio at the Moment
Zacks via Yahoo Singapore Finance· 2 years agoFLEX is benefiting from strength across the Agility Solutions and Reliability Solutions segments,...
Biogen's (BIIB) Lecanemab Meets Goal in Alzheimer's Study
Zacks via Yahoo Singapore Finance· 2 years agoBiogen (BIIB) and Eisai's Clarity AD study showed that treatment with lecanemab in the early stages...